Announced Thu, 30 Apr · 16:50 IST

<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.6%1-day move
₹6.90
prior close
₹6.56
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0-9.6-5.1-0.4-5.4-10.0-10.1-18.8-25.8-18.3
Up moveDown movePending
AI summary

Arunjyoti Bio Ventures Ltd has filed its annual disclosure with BSE confirming that it does not fall under the SEBI definition of a Large Corporate (LC). Under SEBI circular dated October 19, 2023, large corporates have mandatory borrowing requirements through debt securities. The company has reported Nil actual borrowing through debt securities for FY 2025-26, with all relevant fields marked as 'Not Applicable'. The filing also confirms no penalties are applicable for the current block period (FY 2025-26 and FY 2026-27). This is a routine regulatory compliance filing where the company is making a required negative confirmation about its LC status.

Likely market impact

No direct impact on shareholders. This is a routine compliance filing confirming the company is below the threshold for Large Corporate classification, meaning it has no mandatory debt borrowing requirements under SEBI regulations.